You are in
>> Doxil
Customize
Sign in to get personalized recommendations
Search

Related images

Ads


Wiki
Doxorubicin Systematic (IUPAC) name (8S,10S)-10-(4-amino-5-hydroxy-6-methyl- tetrahydro-2H-pyran-2-yloxy) -6,8,11-trihydroxy-8-(2-hydroxyacetyl) -1-methoxy-7,8,9,10-tetrahydrotetracene -5,12-dione Identifiers CAS number 23214-92-8 ATC code L01DB01 PubChem 31703 DrugBank APRD00185 Chemical data Formula C27H29NO11  Mol. mass 543.52 g/mol Pharmacokinetic data Bioavailability 5% (Oral) Metabolism CYP3A4 Half life 12-18.5 hours[1] Excretion Biliary and fecal Therapeutic considerations Pregnancy cat.

D(AU) D(US)

Legal status

POM(UK) ℞-only(US)

Routes Intravenous

Doxorubicin (trade name Adriamycin) or hydroxyldaunorubicin is a drug widely used in cancer chemotherapy. It is an anthracycline antibiotic and structurally closely related to daunomycin, and also intercalates DNA. It is commonly used in the treatment of a wide range of cancers.

The drug is administered by injection. It may be sold under the brand names Adriamycin PFS, Adriamycin RDF, or Rubex.[2] Doxil is a liposome-encapsulated dosage form of doxorubicin made by Ben Venue Laboratories for Johnson & Johnson. The main benefits of this form are a reduction in cardiotoxicity.



Video
Loading...
Last news

MILLENNIUM ANNOUNCES VELCADE(R) (BORTEZOMIB) FOR INJECTION FIRST
Health / Pharmaceuticals   

Millennium Announces VELCADE(R) (Bortezomib) For Injection First
MILLENNIUM PHARMACEUTICA (Full text of a statement. Contact details below.) MEDIA RELEASE PR29864 Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales CAMBRIDGE, Mass., April 10 /PRNewswire-AsiaNet/ --(BUSINESS WIRE) - - Strong U.S. sales growth to $83.5 million, up 13 percent over fourth-quarter 2007 and 42 percent over first-quarter 2007 - Millennium ...

Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
CAMBRIDGE, Mass. ( Map ) - CAMBRIDGE, Mass. , April 10 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM ) today announced first-quarter 2008 U.S. net sales of $83.5 million for its flagship product VELCADE, the global market leader for the treatment of patients with relapsed multiple myeloma.

Top websites

DOXIL—Home Page
DOXIL is indicated for the treatment of patients with ovarian cancer whose ... The use of DOXIL may lead to cardiac toxicity. ...


DOXIL—About DOXIL
Treatment for ovarian cancer. ... DOXIL takes the active agent doxorubicin and places it into a fat bubble called ... coating allows DOXIL to evade detection ...


Doxil® (Doxorubicin HCl Liposome Injection)
The STEALTH® liposomes utilized in Doxil® are formulated with surface-bound ... In multiple myeloma, lower doses of Doxil® are used, and the risk of HFS is much ...


Doxil (Doxorubicin Hcl) drug description - FDA approved labeling for prescription drugs and medications at RxList
Find Doxil (Doxorubicin Hcl) medication description and FDA approved drug information including side effects, interactions and patient labeling.


Doxil and Doxil Side Effects - Chemotherapy Drugs
Doxil is an anti-cancer chemotherapy drug classified as an anthracycline antibiotic. Doxil is ... If Doxil escapes from the vein it can cause tissue damage. ...


Ortho Biotech: DOXIL Product Page
DOXIL® (doxorubicin HCl liposome injection) is an advanced form of the ... Unlike conventional doxorubicin therapy, DOXIL is a liposomal formulation of ...


5. Accidental substitution of DOXIL
of DOXIL (doxorubicin HCI) liposome injection, ... the risk of cardiac toxicity for patients treated with DOXIL. was 11 ... DOXIL. should be administered at an ...


Doxil® (Doxorubicin HCl Liposome Injection)
... efforts led to the development of Doxil®, in which the active drug, doxorubicin, ... the version of VAD with Doxil® had equal efficacy to traditional VAD. ...


DOXIL®
DOXIL® was 11%. Prior use of other anthracyclines or anthracenediones ... DOXIL. should be administered at an ... the pegylated DOXIL. liposomes are able ...


Definition of Doxil - NCI Dictionary of Cancer Terms
Doxil (DOK-sil) ... Doxil is used to treat ovarian cancer, AIDS-related Kaposi sarcoma, and multiple ... Doxil is a type of anthracycline antitumor antibiotic. ...


Posts in groups

US-NJ: Bridgewater-Associate Manager, Rebate Management

.... Ortho Biotech Products, L.P. and its worldwide affiliates market PROCRIT/EPREX/ERYPO (Epoetin alfa), used to treat anemia associated with serious chronic conditions. The company also markets DOXIL (doxorubicin HCl liposome injection) for the treatment of relapsed and refractory ovarian cancer; ORTHOCLONE OKT3 (muromonab-CD3), a monoclonal antibody used to treat organ transplant rejection; and ...

US-NJ: Bridgewater-Associate Manager, Rebate Management

.... Ortho Biotech Products, L.P. and its worldwide affiliates market PROCRIT/EPREX/ERYPO (Epoetin alfa), used to treat anemia associated with serious chronic conditions. The company also markets DOXIL (doxorubicin HCl liposome injection) for the treatment of relapsed and refractory ovarian cancer; ORTHOCLONE OKT3 (muromonab-CD3), a monoclonal antibody used to treat organ transplant rejection; and ...

US-NJ: Bridgewater-Associate Manager, Rebate Management

.... Ortho Biotech Products, L.P. and its worldwide affiliates market PROCRIT/EPREX/ERYPO (Epoetin alfa), used to treat anemia associated with serious chronic conditions. The company also markets DOXIL (doxorubicin HCl liposome injection) for the treatment of relapsed and refractory ovarian cancer; ORTHOCLONE OKT3 (muromonab-CD3), a monoclonal antibody used to treat organ transplant rejection; and ...

doxil and tylenol low blood pressure and lipitor zoloft and blood sugar

... blood, famotidine and tylenol, zestril and tylenol, nursing and tylenol overdose, tylenol and cyanide, blood pressure water pill, crestor high blood pressure, pregnancy and tylenol pain relievers, doxil and tylenol, tylenol cold and flu medicine, phentermine and blood donations, low white blood count and buspar, tylenol and advil together, blood lisinopril pressure, beer and tylenol for ...

US-NJ: Bridgewater-Associate Manager, Rebate Management

.... Ortho Biotech Products, L.P. and its worldwide affiliates market PROCRIT/EPREX/ERYPO (Epoetin alfa), used to treat anemia associated with serious chronic conditions. The company also markets DOXIL (doxorubicin HCl liposome injection) for the treatment of relapsed and refractory ovarian cancer; ORTHOCLONE OKT3 (muromonab-CD3), a monoclonal antibody used to treat organ transplant rejection; and ...

US-NJ: Bridgewater-Associate Manager, Rebate Management

.... Ortho Biotech Products, L.P. and its worldwide affiliates market PROCRIT/EPREX/ERYPO (Epoetin alfa), used to treat anemia associated with serious chronic conditions. The company also markets DOXIL (doxorubicin HCl liposome injection) for the treatment of relapsed and refractory ovarian cancer; ORTHOCLONE OKT3 (muromonab-CD3), a monoclonal antibody used to treat organ transplant rejection; and ...

US-NJ: Bridgewater-Associate Manager, Rebate Management

.... Ortho Biotech Products, L.P. and its worldwide affiliates market PROCRIT/EPREX/ERYPO (Epoetin alfa), used to treat anemia associated with serious chronic conditions. The company also markets DOXIL (doxorubicin HCl liposome injection) for the treatment of relapsed and refractory ovarian cancer; ORTHOCLONE OKT3 (muromonab-CD3), a monoclonal antibody used to treat organ transplant rejection; and ...

US-NJ: Bridgewater-Associate Manager, Rebate Management

.... Ortho Biotech Products, L.P. and its worldwide affiliates market PROCRIT/EPREX/ERYPO (Epoetin alfa), used to treat anemia associated with serious chronic conditions. The company also markets DOXIL (doxorubicin HCl liposome injection) for the treatment of relapsed and refractory ovarian cancer; ORTHOCLONE OKT3 (muromonab-CD3), a monoclonal antibody used to treat organ transplant rejection; and ...

US-NJ: Bridgewater-Associate Manager, Rebate Management

.... Ortho Biotech Products, L.P. and its worldwide affiliates market PROCRIT/EPREX/ERYPO (Epoetin alfa), used to treat anemia associated with serious chronic conditions. The company also markets DOXIL (doxorubicin HCl liposome injection) for the treatment of relapsed and refractory ovarian cancer; ORTHOCLONE OKT3 (muromonab-CD3), a monoclonal antibody used to treat organ transplant rejection; and ...

US-NJ: Bridgewater-Associate Manager, Rebate Management

.... Ortho Biotech Products, L.P. and its worldwide affiliates market PROCRIT/EPREX/ERYPO (Epoetin alfa), used to treat anemia associated with serious chronic conditions. The company also markets DOXIL (doxorubicin HCl liposome injection) for the treatment of relapsed and refractory ovarian cancer; ORTHOCLONE OKT3 (muromonab-CD3), a monoclonal antibody used to treat organ transplant rejection; and ...

Copyright © 2008 ShopInt.com